Results 1 to 10 of about 143,368 (264)

Systolic Blood Pressure Variability When Transitioning From Intravenous to Enteral Antihypertensive Agents in Patients With Hemorrhagic Strokes [PDF]

Frontiers in Neurology, 2022
Background/ObjectiveSystolic blood pressure variability (SBPV) in patients with intracranial hemorrhage (ICH) and subarachnoid hemorrhage (SAH) is associated with an increased risk of acute kidney injury (AKI) and mortality. SBPV is a strong predictor of
Abdulrahman I. Alshaya, Abdulrahman I. Alshaya, Abdulrahman I. Alshaya, Meshari Alghamdi, Meshari Alghamdi, Meshari Alghamdi, Sumaya N. Almohareb, Sumaya N. Almohareb, Sumaya N. Almohareb, Omar A. Alshaya, Omar A. Alshaya, Omar A. Alshaya, Mohammed Aldhaeefi, Mohammed Aldhaeefi, Mohammed Aldhaeefi, Mohammed Aldhaeefi, Abdullah F. Alharthi, Sulaiman Almohaish, Sulaiman Almohaish   +18 more
doaj   +2 more sources

Propranolol as an antihypertensive agent in children. [PDF]

Archives of Disease in Childhood, 1978
The antihypertensive effect of oral propranolol was studied in 9 children with hypertension. After treatment with propranolol, systolic blood pressure fell by an average of 26 mmHg (P less than 0.01). Diastolic pressure decreased by 20 mmHg on average (P less than 0.01). The mean propranolol dose was 2.5 mg/kg per day. Side effects included bradycardia
W R Griswold, S.T. Higgins, B B Sellers, S A Mendoza, R McNeal   +4 more
openaire   +5 more sources

Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. [PDF]

J Am Heart Assoc, 2018
Background Our objective was to determine patterns of antihypertensive agent use by stage of chronic kidney disease (CKD) and to evaluate the association between different classes of antihypertensive agents with nonrenal outcomes, especially in advanced ...
Ku E, McCulloch CE, Vittinghoff E, Lin F, Johansen KL.   +4 more
europepmc   +3 more sources

Cognition and drug adherence to oral hypoglycemic and antihypertensive agents in older adults [PDF]

Patient Preference and Adherence, 2019
Hamzah Bakouni,1,2 Lia Gentil,3 Helen-Maria Vasiliadis1–2,41Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada; 2Centre de recherche Charles-Le Moyne – Saguenay–Lac-Saint-Jean sur les ...
Bakouni H, Gentil L, Vasiliadis HM
doaj   +2 more sources

Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky medication adherence scale [PDF]

, 2013
<b>Background and objectives</b> Poor adherence to medications is one of the major public health challenges. Only one-third of the population reported successful control of blood pressure, mostly caused by poor drug adherence.
AB Morris, AD Hyre, C Lenfant, CA Jackevicius, D. William Cameron, DE Morisky, DE Morisky, Donald E. Morisky, E Degli Esposti, E Yiannakopoulou, F Turnbull, G Levy, G Mancia, Gabrielle K. Y. Lee, GEC Wetzels, Harry H. X. Wang, HR Black, J Jin, K Wolf-Maier, Kirin Q. L. Liu, L Osterberg, LD Esposti, LG Ogden, M Burnier, M Krousel-Wood, M Krousel-Wood, Martin C. S. Wong, MC Wong, MCS Wong, MCS Wong, MCS Wong, MCS Wong, ME Inkster, O Friedman, P Lam, PJ McDonnell, PM Ho, PM Kearney, PS Wang, RB Haynes, S Svensson, SJ Billups, SY Zhang, TM Zyczynski, VL Champion, WC Cushman, WC Gerth, WJ Elliott, Yu Cheung   +48 more
core   +13 more sources

Effectiveness of antihypertensive agents in stage I/II hypertensive patients with ace (I/D) gene polymorphism

Journal of Medical and Scientific Research, 2023
Background: Angiotensin converting enzyme (ACE) is the key enzyme, regulates the blood pressure which is encoded by 21kb gene that consists of 26 exons and is located on chromosome 17, contains a polymorphism in the form of either Insertion (I) or ...
Bansal G, Chaithanya TM, Alam MA, Manchi RK   +3 more
doaj   +1 more source

Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials

Frontiers in Physiology, 2021
Background: Antihypertensive treatment may have different effects on central arterial hemodynamics. The extent of the difference in effects between various antihypertensive drugs remains undefined.Methods: We conducted a systematic review and meta ...
Yi-Bang Cheng, Jia-Hui Xia, Yan Li, Ji-Guang Wang   +3 more
doaj   +1 more source

Withdrawal of antihypertensive medication in young to middle-aged adults: a prospective, single-group, intervention study

Clinical Hypertension, 2023
Background Although antihypertensive drug therapy is commonly believed to be a life-long therapy, several recent guidelines have suggested that antihypertensive medications can be gradually reduced or discontinued for some patients whose blood pressure ...
Hae-Young Lee, Kyoung Suk Lee
doaj   +1 more source

Persistence and Adherence to Cardiovascular Medicines in Australia

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background The burden of cardiovascular disease is increasing, with many people treated for multiple cardiovascular conditions. We examined persistence and adherence to medicines for cardiovascular disease treatment or prevention in Australia.
Juliana de Oliveira Costa, Jialing Lin, Sallie‐Anne Pearson, Nicholas A. Buckley, Andrea L. Schaffer, Michael O. Falster   +5 more
doaj   +1 more source

Renoprotection with antihypertensive agents [PDF]

The Lancet, 2002
Albert Fournier, Hakim Mazouz, R. Makdassi, Claire Presne, Gabriel Choukroun   +4 more
openaire   +3 more sources